For the Inventor, By the Inventor

Enter assignee name

Boehringer Ingelheim (canada) Ltd.

USPTO Granted Patents = 62

Forward Citations = 1,428

Loading Chart...

Loading Chart...

67 inventors (with patents filed for the assignee):

Youla S Tsantrizos (16 out of 37 patents)

Nathalie Goudreau (16 out of 25 patents)

Jean Rancourt (15 out of 39 patents)

4. Montse Llinas-Brunet (14 out of 35 patents)

5. Murray D Bailey (14 out of 35 patents)

6. Dale R Cameron (12 out of 27 patents)

7. Pierre Louis Beaulieu (12 out of 45 patents)

8. Teddy Halmos (12 out of 28 patents)

9. George Kukolj (12 out of 16 patents)

10. Marc-Andre Poupart (11 out of 21 patents)

11. Elise Ghiro (11 out of 21 patents)

12. William W Ogilvie (11 out of 12 patents)

13. Dominik M Wernic (11 out of 13 patents)

14. Anne-Marie Faucher (11 out of 20 patents)

15. Christiane Yoakim (10 out of 44 patents)

Core Competencies:

Hepatitis C Virus

Viral Polymerase Inhibitors

Self-replicating RNA

HCV NS3 Protease

Non-nucleoside Reverse Transcriptase Inhibitors

Papilloma Virus Inhibitors

Macrocyclic Peptides

RSV Polymerase Inhibitors

E1 Helicase

HIV RT Dimerization

Tri-peptides

Graft Animal Model

62 patents: Sort by Forward Citations

1. 7919312 - Self-replicating RNA molecule from hepatitis C virus (2011-04-05),

2. RE42164 - Hepatitis C inhibitor tri-peptides (2011-02-21),

3. 7893084 - Viral polymerase inhibitors (2011-02-22),

4. 7838207 - Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease (2010-11-23),

5. RE41894 - Hepatitis C inhibitor tri-peptides (2010-10-25),

6. 7807670 - Inhibitors of papilloma virus (2010-10-05),

7. RE41356 - Hepatitis C inhibitor tri-peptides (2010-05-24),

8. 7576079 - Viral polymerase inhibitors (2009-08-18),

9. 7528167 - Inhibitors of papilloma virus (2009-05-05),

10. 7439258 - Viral polymerase inhibitors (2008-10-21),

11. RE40525 - Hepatitis C inhibitor tri-peptides (2008-09-29),

12. 7344723 - Self-replicating RNA molecule from hepatitis C virus (2008-03-18),

13. 7323567 - RSV polymerase inhibitors (2008-01-29),

14. 7294457 - Direct binding assay for identifying inhibitors of HCV polymerase (2007-11-13),

15. 7276373 - Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease (2007-10-02),

Boehringer Ingelheim (Canada) Ltd. is a global pharmaceutical company focused on researching, developing, and manufacturing innovative medicines in various therapeutic areas. With a presence in over 150 countries, Boehringer Ingelheim is committed to improving human and animal health. The company's portfolio includes prescription drugs, over-the-counter products, and biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

62 Patents

#23 in

#206 in Canada

#11,476 in the World

Boehringer Ingelheim (canada) Ltd.

Forward Citations = 1,428

67 inventors:

Youla S Tsantrizos (16 out of 37 patents)

Nathalie Goudreau (16 out of 25 patents)

Jean Rancourt (15 out of 39 patents)

4. Montse Llinas-Brunet (14 out of 35 patents)

5. Murray D Bailey (14 out of 35 patents)

Please report any incorrect information to support@idiyas.com

Loading…